Multiple Sclerosis Linked to Lower Risk for Alzheimer Disease Pathology
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 30, 2024 -- Multiple sclerosis (MS) is associated with a lower risk for Alzheimer disease, according to a study published in the September issue of the Annals of Neurology.
Noting that development of typical Alzheimer disease dementia syndrome is uncommon in people with MS, Matthew R. Brier, M.D., Ph.D., from Washington University in St. Louis, and colleagues examined amyloid-β (Aβ) pathology among 100 MS patients compared to 300 age-, sex-, apolipoprotein E proteotype-, and cognitive status-matched controls without MS. The presence of amyloid pathology was measured by the ratio of phosphorylated to nonphosphorylated tau at position 217 (p-tau217), the ratio of Aβ42 to Aβ40 (Aβ42/40 ratio), and amyloid probability score 2 (APS2).
The researchers found that Aβ plasma biomarker positivity was about half the rate in MS patients versus controls. Fewer MS patients were APS2-positive than controls (7.1 versus 15.3 percent); concordantly, fewer MS patients were p-tau217 ratio-positive (9.0 versus 18.3 percent). The Aβ42/40 ratio did not differ for MS patients and controls. Most of the MS patients with Aβ pathology had features that were atypical for MS at diagnosis.
"The present study suggests that MS is associated with a low prevalence of amyloid pathology based on plasma biomarkers," the authors write. "Future studies to confirm and understand the mechanisms of protection from Alzheimer disease may identify new treatment targets."
Several authors disclosed ties to C2N Diagnostics; one author is an inventor on a patent licensed to C2N Diagnostics for therapeutic use of anti-tau antibodies.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2024
Read this next
Dementia Diagnoses Up in Individuals With Acute Kidney Injury
THURSDAY, Sept. 5, 2024 -- Individuals with acute kidney injury (AKI) have an increased risk for receiving a clinical diagnosis of dementia, according to a study published online...
Urinary Cadmium Levels Linked to Cognitive Impairment in Whites
WEDNESDAY, Sept. 4, 2024 -- Among White, but not Black individuals, urinary cadmium (Cd) concentrations are associated with cognitive impairment, according to a study published...
SGLT-2 Inhibitors May Cut Dementia Risk in Patients With Diabetes
TUESDAY, Sept. 3, 2024 -- Sodium-glucose cotransporter-2 (SGLT-2) inhibitors may prevent dementia in middle-aged adults with diabetes, according to a study published online Aug...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.